This combination medicine contains Linagliptin 2.5 mg and Metformin Hydrochloride IP 500 mg, formulated to help manage type 2 diabetes mellitus. Linagliptin is a DPP-4 inhibitor that increases insulin secretion and reduces glucagon levels, helping control blood sugar levels. Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity. Together, this combination works synergistically to maintain optimal blood glucose levels and reduce the risk of diabetes-related complications.
